IBSA Institut Biochimique, S.A. et al v. Teva Pharmaceuticals USA, Inc.
| IBSA Institut Biochimique, S.A., Altergon, S.A., Mist Acquisition, LLC and Mist Pharmaceuticals, LLC |
| Teva Pharmaceuticals USA, Inc. |
| 1:2018cv00555 |
| April 13, 2018 |
| US District Court for the District of Delaware |
| Wilmington Office |
| New Castle |
| Leonard P. Stark |
| Patent - Abbreviated New Drug Application |
| 35 U.S.C. ยง 271 |
| None |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
107
MEMORANDUM OPINION providing claim construction for multiple terms in U.S. Patent No. 7,723,390. Within five days the parties shall submit a proposed order consistent with this Memorandum Opinion. Signed by Judge Richard G. Andrews on 8/16/2019. (nms)
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
